Metraipolis › archive › dc_82da626ca4f9

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study) — Europe PMC PMID:42548788

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42548788
DOI
10.1016/j.mayocpiqo.2026.100739
License (as archived)
solo-consultazione
Archived
2026-10-17T15:27:00.400Z
SHA-256 of the archived text
3b2fde904240e8859fd52c9461b0155ed4c1bd078a30a16ce9f5f23a37ac400b
Stable URL of this page
https://metraipolis.com/documento/dc_82da626ca4f9

How to cite

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study) — Europe PMC PMID:42548788 — Europe PMC (en), https://europepmc.org/article/MED/42548788 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82da626ca4f9 (Metraipolis archive dc_82da626ca4f9, sha256 3b2fde904240e8859fd52c9461b0155ed4c1bd078a30a16ce9f5f23a37ac400b)
BibTeX
@misc{dc82da626ca4f9,
  title = {Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study) — Europe PMC PMID:42548788},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42548788},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82da626ca4f9; sha256 3b2fde904240e8859fd52c9461b0155ed4c1bd078a30a16ce9f5f23a37ac400b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42548788. Agents can read the archived copy with the MCP tool read_document.